These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6345112)

  • 81. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission.
    Eliakim R; Wengrower D; Ligumsky M; Rachmilewitz D
    Isr J Med Sci; 1990 Jan; 26(1):47-9. PubMed ID: 1968895
    [No Abstract]   [Full Text] [Related]  

  • 82. Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
    Kandula M; Sunil Kumar KB; Palanichamy S; Rampal A
    Int Immunopharmacol; 2016 Nov; 40():443-451. PubMed ID: 27716592
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence.
    Desreumaux P; Ghosh S
    Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 1():2-9. PubMed ID: 16939423
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas.
    Barber GB; Lee DE; Antonioli DA; Peppercorn MA
    Am J Gastroenterol; 1985 Aug; 80(8):612-4. PubMed ID: 2862789
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis.
    Sircar JC; Schwender CF; Carethers ME
    Biochem Pharmacol; 1983 Jan; 32(1):170-2. PubMed ID: 6131674
    [No Abstract]   [Full Text] [Related]  

  • 86. Sulphasalazine in ulcerative colitis: in memoriam?
    Hayllar J; Bjarnason I
    Gut; 1991 May; 32(5):462-3. PubMed ID: 1674925
    [No Abstract]   [Full Text] [Related]  

  • 87. Radioiodination of balsalazide, bioevaluation, and characterization as a highly selective radiotracer for imaging of ulcerative colitis in mice.
    Sanad MH; Gomaa NM; El Bakary NM; Ibrahim IT; Massoud A
    J Labelled Comp Radiopharm; 2022 Mar; 65(3):71-82. PubMed ID: 34984721
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Amino acid derivatives of 5-ASA as novel prodrugs for intestinal drug delivery.
    Clerici C; Gentili G; Boschetti E; Santucci C; Aburbeh AG; Natalini B; Pellicciari R; Morelli A
    Dig Dis Sci; 1994 Dec; 39(12):2601-6. PubMed ID: 7995185
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Bacterial acetylation of 5-aminosalicylic acid in faecal suspensions cultured under aerobic and anaerobic conditions.
    van Hogezand RA; Kennis HM; van Schaik A; Koopman JP; van Hees PA; van Tongeren JH
    Eur J Clin Pharmacol; 1992; 43(2):189-92. PubMed ID: 1425876
    [TBL] [Abstract][Full Text] [Related]  

  • 90. New metabolites of the drug 5-aminosalicylic acid. I: N-beta-D-glucopyranosyl-5-aminosalicylic acid.
    Tjørnelund J; Hansen SH; Cornett C
    Xenobiotica; 1989 Aug; 19(8):891-9. PubMed ID: 2815831
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Absorption and excretion of azodisal sodium and its metabolites in man after rectal administration of a single 2-g dose.
    Sandberg-Gertzén H; Ryde M; Järnerot G
    Scand J Gastroenterol; 1983 May; 18(4):571-5. PubMed ID: 6669934
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Balsalazide Exposure During the Development of Fertilizing Sperm May Be Associated With Offspring Birth Defects.
    Wensink MJ; Streett SE; Damkier P; Lindahl-Jacobsen R; Kjeldsen J; Eisenberg ML
    Inflamm Bowel Dis; 2022 Oct; 28(10):1607-1609. PubMed ID: 35259244
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities.
    Martinelli F; Thiele I
    Gut Microbes; 2024; 16(1):2387400. PubMed ID: 39150897
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era.
    Wang S; Ju D; Zeng X
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255298
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Exploring the role of gut microbiota in advancing personalized medicine.
    Huang G; Khan R; Zheng Y; Lee PC; Li Q; Khan I
    Front Microbiol; 2023; 14():1274925. PubMed ID: 38098666
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The Interplay between Gut Microbiota and Oral Medications and Its Impact on Advancing Precision Medicine.
    Mousa S; Sarfraz M; Mousa WK
    Metabolites; 2023 May; 13(5):. PubMed ID: 37233715
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Design, Development, and Optimisation of Smart Linker Chemistry for Targeted Colonic Delivery-In Vitro Evaluation.
    Abd-Ellah HS; Mudududdla R; Carter GP; Baell JB
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678931
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The influence of the gut microbiota on the bioavailability of oral drugs.
    Zhang X; Han Y; Huang W; Jin M; Gao Z
    Acta Pharm Sin B; 2021 Jul; 11(7):1789-1812. PubMed ID: 34386321
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Murray A; Nguyen TM; Parker CE; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD000544. PubMed ID: 32856298
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.